CN107715310A - 一种气血循环量子仓 - Google Patents
一种气血循环量子仓 Download PDFInfo
- Publication number
- CN107715310A CN107715310A CN201711060192.5A CN201711060192A CN107715310A CN 107715310 A CN107715310 A CN 107715310A CN 201711060192 A CN201711060192 A CN 201711060192A CN 107715310 A CN107715310 A CN 107715310A
- Authority
- CN
- China
- Prior art keywords
- parts
- upper cover
- far
- cover body
- infrared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 41
- 229910010293 ceramic material Inorganic materials 0.000 claims abstract description 41
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 26
- 150000001450 anions Chemical class 0.000 claims abstract description 18
- 230000005855 radiation Effects 0.000 claims abstract description 16
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001467 acupuncture Methods 0.000 claims abstract description 4
- 238000009434 installation Methods 0.000 claims abstract description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 28
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 22
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- RCFVMJKOEJFGTM-UHFFFAOYSA-N cerium zirconium Chemical compound [Zr].[Ce] RCFVMJKOEJFGTM-UHFFFAOYSA-N 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000001301 oxygen Substances 0.000 claims description 12
- 229910052760 oxygen Inorganic materials 0.000 claims description 12
- 239000004575 stone Substances 0.000 claims description 12
- LYJTXJJPTFISDL-UHFFFAOYSA-L C([O-])([O-])=O.[Ti+4].[Al+3] Chemical compound C([O-])([O-])=O.[Ti+4].[Al+3] LYJTXJJPTFISDL-UHFFFAOYSA-L 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000004408 titanium dioxide Substances 0.000 claims description 11
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 10
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 10
- 229940070527 tourmaline Drugs 0.000 claims description 10
- 229910052613 tourmaline Inorganic materials 0.000 claims description 10
- 239000011032 tourmaline Substances 0.000 claims description 10
- 238000000498 ball milling Methods 0.000 claims description 9
- 229910010271 silicon carbide Inorganic materials 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- 239000011230 binding agent Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- OERNJTNJEZOPIA-UHFFFAOYSA-N zirconium nitrate Chemical compound [Zr+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O OERNJTNJEZOPIA-UHFFFAOYSA-N 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000005245 sintering Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- -1 ramet Inorganic materials 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 238000005452 bending Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000003763 carbonization Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 229910052715 tantalum Inorganic materials 0.000 description 3
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000033904 relaxation of vascular smooth muscle Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001839 systemic circulation Effects 0.000 description 2
- 210000001103 thalamus Anatomy 0.000 description 2
- 239000002550 vasoactive agent Substances 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H9/00—Pneumatic or hydraulic massage
- A61H9/005—Pneumatic massage
- A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/14—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silica
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/16—Physical interface with patient
- A61H2201/1683—Surface of interface
- A61H2201/169—Physical characteristics of the surface, e.g. material, relief, texture or indicia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2205/00—Devices for specific parts of the body
- A61H2205/08—Trunk
- A61H2205/081—Back
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
- C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3217—Aluminum oxide or oxide forming salts thereof, e.g. bauxite, alpha-alumina
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3224—Rare earth oxide or oxide forming salts thereof, e.g. scandium oxide
- C04B2235/3229—Cerium oxides or oxide-forming salts thereof
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3231—Refractory metal oxides, their mixed metal oxides, or oxide-forming salts thereof
- C04B2235/3232—Titanium oxides or titanates, e.g. rutile or anatase
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3231—Refractory metal oxides, their mixed metal oxides, or oxide-forming salts thereof
- C04B2235/3244—Zirconium oxides, zirconates, hafnium oxides, hafnates, or oxide-forming salts thereof
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3427—Silicates other than clay, e.g. water glass
- C04B2235/3463—Alumino-silicates other than clay, e.g. mullite
- C04B2235/3472—Alkali metal alumino-silicates other than clay, e.g. spodumene, alkali feldspars such as albite or orthoclase, micas such as muscovite, zeolites such as natrolite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3427—Silicates other than clay, e.g. water glass
- C04B2235/3463—Alumino-silicates other than clay, e.g. mullite
- C04B2235/3481—Alkaline earth metal alumino-silicates other than clay, e.g. cordierite, beryl, micas such as margarite, plagioclase feldspars such as anorthite, zeolites such as chabazite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/38—Non-oxide ceramic constituents or additives
- C04B2235/3817—Carbides
- C04B2235/3826—Silicon carbides
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/38—Non-oxide ceramic constituents or additives
- C04B2235/3817—Carbides
- C04B2235/3839—Refractory metal carbides
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/38—Non-oxide ceramic constituents or additives
- C04B2235/3852—Nitrides, e.g. oxynitrides, carbonitrides, oxycarbonitrides, lithium nitride, magnesium nitride
- C04B2235/3856—Carbonitrides, e.g. titanium carbonitride, zirconium carbonitride
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/38—Non-oxide ceramic constituents or additives
- C04B2235/3852—Nitrides, e.g. oxynitrides, carbonitrides, oxycarbonitrides, lithium nitride, magnesium nitride
- C04B2235/3865—Aluminium nitrides
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/38—Non-oxide ceramic constituents or additives
- C04B2235/3852—Nitrides, e.g. oxynitrides, carbonitrides, oxycarbonitrides, lithium nitride, magnesium nitride
- C04B2235/3886—Refractory metal nitrides, e.g. vanadium nitride, tungsten nitride
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/70—Aspects relating to sintered or melt-casted ceramic products
- C04B2235/96—Properties of ceramic products, e.g. mechanical properties such as strength, toughness, wear resistance
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Ceramic Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Rehabilitation Therapy (AREA)
- Manufacturing & Machinery (AREA)
- Organic Chemistry (AREA)
- Structural Engineering (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Pathology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
本发明提供了一种气血循环量子仓，包括：包括由远红外陶瓷材料制造而成的下舱体和上盖体，下舱体和上盖体之间通过尾部连接块连接，并且通过两个并行设置在尾部连接块左右两侧的升降气缸实现上盖体的起降，上盖体的内侧沿上盖体的中心线从前往后依次安装有远红外照射灯、近红外量子灯和负离子发生器，上盖体的内侧根据人体的穴位分布安装有多个锗石和磁石，上盖体的前端设置有控制面板，下舱体内铺设有纳米石墨烯垫，纳米石墨烯垫上安装有多个按摩气囊，纳米石墨烯垫的前端还设置有按摩枕。本气血循环量子仓可以通过远红外照射灯、近红外量子灯、负离子发生器、锗石、磁石以及纳米石墨烯垫的配合，可以根据不同人群的需求促进人体的气血循环。
Description
技术领域
本发明涉及医疗器械领域，具体涉及一种气血循环量子仓。
背景技术
目前，市场销售的保健舱，包括由气密性材料制成的能敞开和闭合的舱体，舱体的顶面上设有供人体头部伸出的缺口，在舱体的内腔中安置有发热器，发热器括外壳，外壳的前后面板均呈网状，外壳的内腔中装有发热元件，发热元件的后侧设置风扇。这种保健舱保健功能单一，使用过程中舱体内易产生异味，无法适应不同人群的需求。
发明内容
针对现有技术的不足，本发明设计了一种气血循环量子仓，本气血循环量子仓可以通过远红外照射灯、近红外量子灯、负离子发生器、锗石以及纳米石墨烯垫的配合，根据不同人群的需求促进人体的气血循环。
为实现上述技术方案，本发明提供了一种气血循环量子仓，包括由远红外陶瓷材料制成的下舱体和上盖体，所述下舱体和上盖体之间通过尾部连接块连接，并且通过两个并行设置在尾部连接块左右两侧的升降气缸实现上盖体的起降，所述上盖体的内侧沿上盖体的中心线从前往后依次安装有远红外照射灯、近红外量子灯和负离子发生器，所述上盖体的内侧根据人体的穴位分布安装有多个锗石和磁石，所述上盖体的前端设置有控制面板，所述下舱体内铺设有纳米石墨烯垫，所述纳米石墨烯垫上安装有多个按摩气囊，所述纳米石墨烯垫的前端还设置有按摩枕。
在上述技术方案中，纳米石墨烯垫铺设在下舱体内，人体可以直接躺放在纳米石墨烯垫上，然后通过升降气缸将上盖体和下舱体盖合，人体的头部露出上盖体以外，通过控制面板可以控制远红外照射灯、近红外量子灯和负离子发生器中任意一个的启闭，以满足不同人群进行保健的需求，其中远红外照射灯发射远红外线，由于远红外线与人体内细胞分子的振动频率接近，“生命光波”渗入体内之后，便会引起人体细胞的原子和分子的共振，透过共鸣吸收，分子之间摩擦生热形成热反应，促使皮下深层温度上升，并使微血管扩张，加速血液循环，有利于清除血管囤积物及体内有害物质。近红外量子灯利用电磁波激发近红外量子点产生近红外光，人体吸收大量近红外光波以后，通过热效应一方面使皮肤温度升高，刺激了皮内热感应器，通过丘脑反射使血管平滑肌松弛，血管扩张血流加快，另一方面引起血管活性物质的释放，血管张力降低，使小动脉、毛细动脉及毛细静脉扩张，促使血流加快，从而带动人大循环的加快。负离子发生器产生的负离子可改变肌体反应能力，活跃网状内皮系统的机能，增强肌体免疫力，激活肌体多种酶，促进新陈代谢，同时还具有消除舱体内异味的效果。通过根据人体穴位排布的锗石，锗石具有调整人体不正常电位的功能，在癌细胞电位剧烈上升时，锗元素会夺取癌细胞的电子，使它电位下降，抑制病症的恶化，同时还具有提升体温，从而促进血液循环，减轻疲劳的功能。根据人体特定穴位排布的磁石，可以形成一个特定的磁场，具有安神养身的功效。纳米石墨烯垫具有自发热的功能，而且可以自发产生远红外线，可以适当提升人体背部的温度，促进人体血液循环，同时通过安装在纳米石墨烯垫上的按摩气囊，可以对人体背部进行气动按摩，促进人体循环，按摩枕头可以促进人体脑部血液循环。如此一来，本气血循环量子仓可以通过远红外照射灯、近红外量子灯、负离子发生器、锗石以及纳米石墨烯垫、按摩气囊的配合，根据不同人群的需求促进人体的气血循环。
在本发明气血循环量子仓中，其下舱体和上盖体均由远红外陶瓷材料制造而成，所述远红外陶瓷材料，按重量份数计，主要由如下组分组成：托玛琳石1～3份、二氧化硅15～25份、二氧化钛5～10份、铈锆复合氧化物8～15份、α-氧化铝4～8份、碳化硅1～3份、碳化钽0.5～2份、氮碳化铝钛0.05～0.2份和碳酸钙5～15份。
本发明所述远红外陶瓷材料在不需要通电或加热的情况下也能产生远红外线，即，在不通电的情况下，下舱体和上盖体也能利用远红外陶瓷材料自身的特性向外发射远红外线，增强周围空气中的的负离子浓度，有利于人体健康。本发明所述远红外陶瓷材料具有较高的远红外辐射发射率，在T＝300K的测试条件下，其法向全发射率在0.85以上。
此外，本发明远红外陶瓷材料还具有显著的耐磨损耐腐蚀性能，其抗弯强度大于450MPa，断裂韧性KIC大于10MPa·m1/2，力学性能好，用于制备气血循环量子仓的下舱体和上盖体，能长时间维持气血循环量子仓的外表完整、美观，同时也显著延长了气血循环量子仓的使用寿命。
优选的，所述远红外陶瓷材料，按重量份数计，主要由如下组分组成：托玛琳石2份、二氧化硅25份、二氧化钛8份、铈锆复合氧化物10份、α-氧化铝6份、碳化硅2份、碳化钽1份、氮碳化铝钛0.1份和碳酸钙10份。
优选的，所述铈锆复合氧化物的制备方法包括如下步骤：取硝酸铈和硝酸锆，按摩尔比(2～4):1混合，按固液比0.05～0.1g/mL加水，搅拌至完全溶解，在不断搅拌的条件下加入质量百分数为15～20％的氨水至溶液pH为9.5～11；静置1～2h，过滤，滤渣用水洗涤至滤液pH为7～8；将洗涤后的滤渣在温度为120℃的条件下干燥10～15h；在温度为600℃的条件下煅烧4～5h，即得铈锆复合氧化物。
优选的，所述远红外陶瓷材料，按重量份数计，还包括粘结剂2～5份，所述粘结剂可选用质量分数为3～5％的聚乙烯醇水溶液、质量分数为4～8％的甲基纤维素水溶液或其他粘结剂，优选5％的聚乙烯醇水溶液。
优选的，所述所述远红外陶瓷材料的制备方法包括如下步骤：
(1)称取托玛琳石、二氧化硅、二氧化钛、铈锆复合氧化物、α-氧化铝、碳化硅、碳化钽、氮碳化铝钛和碳酸钙，分别制成粉体，混合均匀后以水作为球磨介质进行球磨，料液比为1:(1.0～1.5)g/mL，球磨至最大颗粒度小于3微米；
(2)将混合球磨好的配料干燥，粉碎，加入粘结剂，搅拌均匀，成型，制成压坯；然后在氮气的保护下进行烧结，烧结温度为1100～1300℃，烧结保温时间为0.5～2h，即得所述远红外陶瓷材料。
其中，步骤(2)所述成型方式可选用常规的模压成型、挤压成型、注射成型等成型方式。
优选的，所述控制面板包括显示屏、触控屏、开关旋钮和调节旋钮，所述触控屏安装在显示屏下方，开关旋钮和调节旋钮分别安装在触控屏的左右两侧，电源插头设置在开关旋钮的下方。本气血循环量子仓的工作状态可以通过显示屏显示，并且通过触控屏可以调节气血循环量子仓的各个工作参数，开关旋钮用于控制远红外照射灯、近红外量子灯和负离子发生器的启闭，调节旋钮用于调节各个部件的工作功率大小。通过控制面板上的各个部件，可以实现本气血循环量子仓的自动控制。
优选的，所述触控屏的左右两侧还安装有多个指示灯。通过指示灯可以直观的反应本量子仓工作时可能发生的故障。
优选的，所述下舱体的侧端面上还设置有进气插头，所述下舱体前端内侧靠近人体头部区设置有氧气喷头。通过进气插头可以控制按摩气囊的气量，以便适应不同使用者的要求，提高舒适度，氧气喷头可以将下舱体内氧循环装置制造的氧气从人体平躺时的头部喷出，增强舒适性。
本发明提供的一种气血循环量子仓的有益效果在于：
本气血循环量子可以促进血液循环，随着温度升高远红外线、近红外线和磁场迅速激活细胞，增加分子振动的频率，促使体内毒素堆积融于人体的无机盐等通过温度的升高迅速排出体外，舱体随着温度的升高，石墨烯远红外线和磁场、锗石及负离子发生器之间的配合使舱体的负氧离子迅速提高，使人体湿毒于人体的寒气排出去体外，循环往复多次使用循环舱体从而达到减肥瘦身排毒养颜，对人体肿瘤，血瘀堵，气血循环不畅等减缓疾病发生，提高免疫系统功能，从而达到防病治病的效果。同时按摩气囊和氧气喷头的存在可以增强用户体验的舒适性。
附图说明
图1为本发明的立体结构示意图。
图2为本发明中纳米石墨烯垫的示意图。
图中：1、下舱体；2、上盖体；3、尾部连接块；4、升降气缸；5、远红外照射灯；6、近红外量子灯；7、负离子发生器；81、锗石；82、磁石；9、显示屏；10、触控屏；11、指示灯；12、开关旋钮；13、调节旋钮；14、电源插头；15、氧气喷头；16、进气插头；17、纳米石墨烯垫；18、按摩气囊；19、按摩枕。
具体实施方式
下面将结合本发明实施例中的附图，对本发明实施例中的技术方案进行清楚、完整的描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。本领域普通人员在没有做出创造性劳动前提下所获得的所有其他实施例，均属于本发明的保护范围。
实施例1铈锆复合氧化物的制备
取硝酸铈和硝酸锆，按摩尔比3:1混合，按固液比0.08g/mL加水，搅拌至完全溶解，在不断搅拌的条件下加入质量百分数为15％的氨水至溶液pH为10；静置2h，过滤，滤渣用水洗涤至滤液pH为7～8；将洗涤后的滤渣在温度为120℃的条件下干燥12h；在温度为600℃的条件下煅烧5h，即得铈锆复合氧化物。
实施例2块状远红外陶瓷材料的制备
按重量份数计，本发明实施例块状远红外陶瓷材料由如下组分组成：托玛琳石1份、二氧化硅25份、二氧化钛7份、实施例1制得的铈锆复合氧化物12份、α-氧化铝6份、碳化硅3份、碳化钽0.5份、氮碳化铝钛0.05份、碳酸钙10份和质量分数为3％的聚乙烯醇水溶液4份。
制备方法：
(1)称取托玛琳石、二氧化硅、二氧化钛、铈锆复合氧化物、α-氧化铝、碳化硅、碳化钽、氮碳化铝钛和碳酸钙，分别制成粉体，混合均匀后以水作为球磨介质进行球磨，料液比为1:1.2g/mL，球磨至最大颗粒度小于3微米；
(2)将混合球磨好的配料干燥，粉碎，加入粘结剂，搅拌均匀，倒入80mm×120mm的模具中，压制成型，制成压坯；然后在氮气的保护下进行烧结，烧结温度为1250℃，烧结保温时间为1.5h，即得块状远红外陶瓷材料样品。
在T＝300K的测试条件下，测得上述块状远红外陶瓷材料样品的法向全发射率为0.86。经测试，上述块状远红外陶瓷材料样品的抗弯强度为460MPa，断裂韧性KIC为11.42MPa·m1/2。
实施例3块状远红外陶瓷材料的制备
按重量份数计，本发明实施例块状远红外陶瓷材料由如下组分组成：托玛琳石3份、二氧化硅18份、二氧化钛5份、实施例1制得的铈锆复合氧化物8份、α-氧化铝8份、碳化硅1份、碳化钽2份、氮碳化铝钛0.15份、碳酸钙15份和质量分数为5％的甲基纤维素水溶液3份。
制备方法同实施例2。
在T＝300K的测试条件下，测得上述块状远红外陶瓷材料样品的法向全发射率为0.85。经测试，上述块状远红外陶瓷材料样品的抗弯强度为480MPa，断裂韧性KIC为12.26MPa·m1/2。
实施例4块状远红外陶瓷材料的制备
按重量份数计，本发明实施例块状远红外陶瓷材料由如下组分组成：托玛琳石2份、二氧化硅25份、二氧化钛8份、铈锆复合氧化物10份、α-氧化铝6份、碳化硅2份、碳化钽1份、氮碳化铝钛0.1份、碳酸钙10份和质量分数为5％的聚乙烯醇水溶液3份。
制备方法同实施例2。
在T＝300K的测试条件下，测得上述块状远红外陶瓷材料样品的法向全发射率为0.88。经测试，上述块状远红外陶瓷材料样品的抗弯强度为510MPa，断裂韧性KIC为12.78MPa·m1/2。
对比例1
与实施例4相比，对比例1块状远红外陶瓷材料区别在于：将铈锆复合氧化物替换为氧化铈和氧化锆按摩尔比3:1组成的混合氧化物。
在T＝300K的测试条件下，测得对比例1块状远红外陶瓷材料样品的法向全发射率为0.82。经测试，对比例1块状远红外陶瓷材料样品的抗弯强度为400MPa，断裂韧性KIC为8.42MPa·m1/2。
对比例2
与实施例4相比，对比例2块状远红外陶瓷材料区别在于：不加碳化钽。
在T＝300K的测试条件下，测得对比例2块状远红外陶瓷材料样品的法向全发射率为0.84。经测试，对比例2块状远红外陶瓷材料样品的抗弯强度为380MPa，断裂韧性KIC为7.18MPa·m1/2。
对比例3
与实施例4相比，对比例3块状远红外陶瓷材料区别在于：不加氮碳化铝钛。
在T＝300K的测试条件下，测得对比例3块状远红外陶瓷材料样品的法向全发射率为0.80。经测试，对比例3块状远红外陶瓷材料样品的抗弯强度为320MPa，断裂韧性KIC为6.06MPa·m1/2。
实施例5一种气血循环量子仓
参照图1和图2所示，一种气血循环量子仓，包括下舱体1和上盖体2，所述下舱体1和上盖体2之间通过尾部连接块3连接，并且通过两个并行设置在尾部连接块3左右两侧的升降气缸4实现上盖体2的起降，所述上盖体2的内侧沿上盖体2的中心线从前往后依次安装有远红外照射灯5、近红外量子灯6和负离子发生器7，所述上盖体2的内侧根据人体的穴位分布安装有多个锗石81和磁石82，所述上盖体2的前端设置有控制面板，所述下舱体1内铺设有纳米石墨烯垫17，所述纳米石墨烯垫17上安装有多个按摩气囊18，所述纳米石墨烯垫17的前端还设置有按摩枕19。
本实施例中，纳米石墨烯垫17铺设在下舱体1内，人体可以直接躺放在纳米石墨烯垫17上，然后通过升降气缸4将上盖体2和下舱体1盖合，人体的头部露出上盖体2以外，通过控制面板可以控制远红外照射灯5、近红外量子灯6和负离子发生器7中任意一个的启闭，以满足不同人群进行保健的需求，其中远红外照射灯5发射远红外线，由于远红外线与人体内细胞分子的振动频率接近，“生命光波”渗入体内之后，便会引起人体细胞的原子和分子的共振，透过共鸣吸收，分子之间摩擦生热形成热反应，促使皮下深层温度上升，并使微血管扩张，加速血液循环，有利于清除血管囤积物及体内有害物质。近红外量子灯6利用电磁波激发近红外量子点产生近红外光，人体吸收大量近红外光波以后，通过热效应一方面使皮肤温度升高，刺激了皮内热感应器，通过丘脑反射使血管平滑肌松弛，血管扩张血流加快，另一方面引起血管活性物质的释放，血管张力降低，使小动脉、毛细动脉及毛细静脉扩张，促使血流加快，从而带动人大循环的加快。负离子发生器7产生的负离子可改变肌体反应能力，活跃网状内皮系统的机能，增强肌体免疫力，激活肌体多种酶，促进新陈代谢，同时还具有消除舱体内异味的效果。通过根据人体穴位排布的锗石81，具有调整人体不正常电位的功能，在癌细胞电位剧烈上升时，锗元素会夺取癌细胞的电子，使它电位下降，抑制病症的恶化，同时还具有提升体温，从而促进血液循环，减轻疲劳的功能。根据人体特定穴位排布的磁石82，可以形成一个特定的磁场，具有安神养身的功效。纳米石墨烯垫17具有自发热的功能，而且可以自发产生远红外线，促进人体血液循环，同时通过安装在纳米石墨烯垫17上的按摩气囊18，可以对人体背部进行气动按摩，促进人体血液循环，按摩枕头19可以促进人体脑部血液循环。如此一来，本气血循环量子仓可以通过远红外照射灯5、近红外量子灯6、负离子发生器7、锗石81、磁石82以及纳米石墨烯垫17、按摩气囊18的配合，根据不同人群的需求促进人体的气血循环。
本实施例中，所述下舱体1和上盖体2均由实施例4所述远红外陶瓷材料制造而成，即使不通电的情况下，下舱体1和上盖体2也能利用远红外陶瓷自身的特性向外发射远红外线，增强周围空气中的的负离子浓度，利于人体健康。
参照图1所示，所述控制面板包括显示屏9、触控屏10、开关旋钮12和调节旋钮13，所述触控屏10安装在显示屏9下方，开关旋钮12和调节旋钮13分别安装在触控屏10的左右两侧，电源插头14设置在开关旋钮12的下方。本气血循环量子仓的工作状态可以通过显示屏9显示，并且通过触控屏10可以调节气血循环量子仓的各个工作参数，开关旋钮12用于控制远红外照射灯5、近红外量子灯6和负离子发生器7的启闭，调节旋钮13用于调节各个部件的工作功率大小。通过控制面板上的各个部件，可以实现本气血循环量子仓的自动控制。
参照图1所示，所述触控屏10的左右两侧还安装有多个指示灯11。通过指示灯11可以直观的反应本量子仓工作时可能发生的故障。
参照图1所示，所述下舱体1的侧端面上还设置有进气插头16，所述下舱体1前端内侧靠近人体头部区设置有氧气喷头15。通过进气插头16可以控制按摩气囊18的气量，以便适应不同使用者的要求，提高舒适度，氧气喷头15可以将下舱体1内氧循环装置制造的氧气从人体平躺时的头部喷出，增强舒适性。
以上所述为本发明的较佳实施例而已，但本发明不应局限于该实施例和附图所公开的内容，所以凡是不脱离本发明所公开的精神下完成的等效或修改，都落入本发明保护的范围。
Claims (8)
1.一种气血循环量子仓，其特征在于：包括由远红外陶瓷材料制造而成的下舱体和上盖体；所述远红外陶瓷材料，按重量份数计，主要由如下组分组成：托玛琳石1～3份、二氧化硅15～25份、二氧化钛5～10份、铈锆复合氧化物8～15份、α-氧化铝4～8份、碳化硅1～3份、碳化钽0.5～2份、氮碳化铝钛0.05～0.2份和碳酸钙5～15份；所述下舱体和上盖体之间通过尾部连接块连接，并且通过两个并行设置在尾部连接块左右两侧的升降气缸实现上盖体的起降，所述上盖体的内侧沿上盖体的中心线从前往后依次安装有远红外照射灯、近红外量子灯和负离子发生器，所述上盖体的内侧根据人体的穴位分布安装有多个锗石和磁石，所述上盖体的前端设置有控制面板，所述下舱体内铺设有纳米石墨烯垫，所述纳米石墨烯垫上安装有多个按摩气囊，所述纳米石墨烯垫的前端还设置有按摩枕。
2.如权利要求1所述的气血循环量子仓，其特征在于：所述远红外陶瓷材料，按重量份数计，主要由如下组分组成：托玛琳石2份、二氧化硅25份、二氧化钛8份、铈锆复合氧化物10份、α-氧化铝6份、碳化硅2份、碳化钽1份、氮碳化铝钛0.1份和碳酸钙10份。
3.如权利要求2所述的气血循环量子仓，其特征在于：所述铈锆复合氧化物的制备方法包括如下步骤：取硝酸铈和硝酸锆，按摩尔比(2～4):1混合，按固液比0.05～0.1g/mL加水，搅拌至完全溶解，在不断搅拌的条件下加入质量百分数为15～20％的氨水至溶液pH为9.5～11；静置1～2h，过滤，滤渣用水洗涤至滤液pH为7～8；将洗涤后的滤渣在温度为120℃的条件下干燥10～15h；在温度为600℃的条件下煅烧4～5h，即得铈锆复合氧化物。
4.如权利要求1～3任一所述的气血循环量子仓，其特征在于：所述远红外陶瓷材料，按重量份数计，还包括粘结剂2～5份。
5.如权利要求4所述的气血循环量子仓，其特征在于：所述远红外陶瓷材料的制备方法包括如下步骤：
(1)称取托玛琳石、二氧化硅、二氧化钛、铈锆复合氧化物、α-氧化铝、碳化硅、碳化钽、氮碳化铝钛和碳酸钙，分别制成粉体，混合均匀后以水作为球磨介质进行球磨，料液比为1:(1.0～1.5)g/mL，球磨至最大颗粒度小于3微米；
(2)将混合球磨好的配料干燥，粉碎，加入粘结剂，搅拌均匀，成型，制成压坯；然后在氮气的保护下进行烧结，烧结温度为1100～1300℃，烧结保温时间为0.5～2h，即得所述远红外陶瓷材料。
6.如权利要求1所述的气血循环量子仓，其特征在于：所述控制面板包括显示屏、触控屏、开关旋钮和调节旋钮，所述触控屏安装在显示屏下方，开关旋钮和调节旋钮分别安装在触控屏的左右两侧。
7.如权利要求6所述的气血循环量子仓，其特征在于：所述触控屏的左右两侧还安装有多个指示灯。
8.如权利要求1所述的气血循环量子仓，其特征在于：所述下舱体的侧端面上还设置有进气插头，所述下舱体前端内侧靠近人体头部区设置有氧气喷头。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711060192.5A CN107715310A (zh) | 2017-11-01 | 2017-11-01 | 一种气血循环量子仓 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711060192.5A CN107715310A (zh) | 2017-11-01 | 2017-11-01 | 一种气血循环量子仓 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107715310A true CN107715310A (zh) | 2018-02-23 |
Family
ID=61222115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711060192.5A Pending CN107715310A (zh) | 2017-11-01 | 2017-11-01 | 一种气血循环量子仓 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107715310A (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108211124A (zh) * | 2018-03-09 | 2018-06-29 | 利每家科技有限公司 | 一种量子人体优化器 |
| CN108685654A (zh) * | 2018-06-11 | 2018-10-23 | 胡杨 | 近红外增氧治疗舱 |
| CN109106541A (zh) * | 2018-10-13 | 2019-01-01 | 深圳佰森大健康管理有限公司 | 人体石墨烯量子共振保健舱 |
| CN110547526A (zh) * | 2019-09-11 | 2019-12-10 | 徐州市颐康量子科技有限公司 | 一种自发热的量子矿石磁疗护颈带及其制备方法 |
| CN111821164A (zh) * | 2020-07-27 | 2020-10-27 | 河南叁叁量子科技有限公司 | 一种全息多频缓压舱 |
| CN111821163A (zh) * | 2020-07-27 | 2020-10-27 | 河南叁叁量子科技有限公司 | 一种多频谱热疗美容养生舱 |
| CN112076047A (zh) * | 2020-09-11 | 2020-12-15 | 湖北医药学院附属襄阳市第一人民医院 | 一种基于低频rTMS结合红外线的治疗肢体运动功能障碍的装置 |
| CN112245175A (zh) * | 2020-09-29 | 2021-01-22 | 广州富尔乐健康科技股份有限公司 | 一种石墨烯波动舱 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087330A (zh) * | 1992-11-21 | 1994-06-01 | 吴建 | 稀土远红外陶瓷微粉的制备及其应用 |
| US7481833B2 (en) * | 2003-12-23 | 2009-01-27 | Michel Dussault | Therapeutic chest |
| CN102040372A (zh) * | 2009-10-12 | 2011-05-04 | 金春南 | 远红外陶瓷及其制备方法 |
| CN202386898U (zh) * | 2011-11-11 | 2012-08-22 | 上海欧玛医疗器械有限公司 | 敞开式多功能身心减压舱 |
| CN205516020U (zh) * | 2016-01-20 | 2016-08-31 | 高锐 | 一种便携式智能感应红外理疗仪 |
| CN205850010U (zh) * | 2016-01-26 | 2017-01-04 | 广州三高医药科技有限公司 | 一种半卧式三高理疗舱 |
| CN206239063U (zh) * | 2016-09-21 | 2017-06-13 | 西安门捷列夫新材料科技有限公司 | 一种石墨烯发热智能地垫 |
-
2017
- 2017-11-01 CN CN201711060192.5A patent/CN107715310A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1087330A (zh) * | 1992-11-21 | 1994-06-01 | 吴建 | 稀土远红外陶瓷微粉的制备及其应用 |
| US7481833B2 (en) * | 2003-12-23 | 2009-01-27 | Michel Dussault | Therapeutic chest |
| CN102040372A (zh) * | 2009-10-12 | 2011-05-04 | 金春南 | 远红外陶瓷及其制备方法 |
| CN202386898U (zh) * | 2011-11-11 | 2012-08-22 | 上海欧玛医疗器械有限公司 | 敞开式多功能身心减压舱 |
| CN205516020U (zh) * | 2016-01-20 | 2016-08-31 | 高锐 | 一种便携式智能感应红外理疗仪 |
| CN205850010U (zh) * | 2016-01-26 | 2017-01-04 | 广州三高医药科技有限公司 | 一种半卧式三高理疗舱 |
| CN206239063U (zh) * | 2016-09-21 | 2017-06-13 | 西安门捷列夫新材料科技有限公司 | 一种石墨烯发热智能地垫 |
Non-Patent Citations (2)
| Title |
|---|
| 刘建军，徐香兰，刘文明，王翔: "不同铈和锆前体对铈锆固溶体性能的影响", 《南昌大学学报（理科版）》 * |
| 周书助: "《硬质材料与工具》", 31 August 2015 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108211124A (zh) * | 2018-03-09 | 2018-06-29 | 利每家科技有限公司 | 一种量子人体优化器 |
| CN108685654A (zh) * | 2018-06-11 | 2018-10-23 | 胡杨 | 近红外增氧治疗舱 |
| CN109106541A (zh) * | 2018-10-13 | 2019-01-01 | 深圳佰森大健康管理有限公司 | 人体石墨烯量子共振保健舱 |
| CN110547526A (zh) * | 2019-09-11 | 2019-12-10 | 徐州市颐康量子科技有限公司 | 一种自发热的量子矿石磁疗护颈带及其制备方法 |
| CN111821164A (zh) * | 2020-07-27 | 2020-10-27 | 河南叁叁量子科技有限公司 | 一种全息多频缓压舱 |
| CN111821163A (zh) * | 2020-07-27 | 2020-10-27 | 河南叁叁量子科技有限公司 | 一种多频谱热疗美容养生舱 |
| CN112076047A (zh) * | 2020-09-11 | 2020-12-15 | 湖北医药学院附属襄阳市第一人民医院 | 一种基于低频rTMS结合红外线的治疗肢体运动功能障碍的装置 |
| CN112076047B (zh) * | 2020-09-11 | 2022-05-31 | 湖北医药学院附属襄阳市第一人民医院 | 一种基于低频rTMS结合红外线的治疗肢体运动功能障碍的装置 |
| CN112245175A (zh) * | 2020-09-29 | 2021-01-22 | 广州富尔乐健康科技股份有限公司 | 一种石墨烯波动舱 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107715310A (zh) | 一种气血循环量子仓 | |
| CN107089827A (zh) | 无机宽波远红外复合环保材料 | |
| KR20180079494A (ko) | 자기장·원적외선·산소를 통한 쓰리이펙트형 스마트 캡슐형 치료기 | |
| CN102847236A (zh) | 远红外电脉冲微针稀土磁疗生物阴阳调和仪 | |
| CN206837239U (zh) | 一种多功能磁性件及远红外和负离子磁功能养生装置 | |
| CN207101638U (zh) | 石墨烯光波理疗装置及理疗床 | |
| CN108815716A (zh) | 一种具有理疗功效的热风机 | |
| CN209171801U (zh) | 一种远红外加热玉石保健床垫 | |
| CN109463938A (zh) | 一种脉冲式升降旋磁按摩床垫及其控制方法和按摩床 | |
| CN105079961B (zh) | 眼部按摩装置及控制方法 | |
| CN207384416U (zh) | 负离子养生舱 | |
| CN204815391U (zh) | 经络拔灸装置 | |
| CN201088698Y (zh) | 一种多功能健身球 | |
| CN209269126U (zh) | 一种碳纤维电热保健床垫 | |
| CN201123588Y (zh) | 玉石垫 | |
| CN106490911A (zh) | 一种具有增效保健效果的玉石颈椎枕 | |
| CN209235586U (zh) | 一种新型医疗保健枕 | |
| CN203137701U (zh) | 一种保健理疗床体 | |
| CN110860044A (zh) | 一种磁疗保健硅胶片及其加工方法 | |
| CN206463203U (zh) | 具有远红外发热功能的按摩棒 | |
| CN206423899U (zh) | 一种带容腔的功能被 | |
| CN206026178U (zh) | 一种双开门式远红外健康理疗足浴桶 | |
| CN206081344U (zh) | 多功能保健仪器 | |
| CN111374820A (zh) | 一种疏通经络与血管的超长波温控保健垫 | |
| CN211834962U (zh) | 一种多功能健康理疗垫 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180223 |
|
| RJ01 | Rejection of invention patent application after publication |